The global prepacked chromatography columns market grew at a CAGR of around 8% during 2014-2019.
Prepacked chromatography columns refer to pre-filled columns used for the decontamination of specific chemical compounds from mixtures. They are commonly used for various chromatography procedures, such as ion exchange, hydrophobic stationary phase, multimodal, etc. They aid in managing the otherwise time-consuming and laborious process of packing the chromatography columns, thereby providing more time for processing the chemicals. They also eliminate the need to clean hardware and enable the users to test multiple chromatography resins for media evaluation at the same time. Owing to this, they find extensive applications in pharmaceutical, biotechnological, food and beverage and research applications.
Significant growth in the pharmaceutical industry, along with increasing product utilization in drug discovery and biological research, is one of the key factors creating a positive outlook for the market. Manufacturers are using prepackaged chromatography columns to produce vaccines and monoclonal antibodies that are cost-effective and can aid in treating rare and new diseases. Furthermore, widespread adoption of prepacked chromatography columns in the agriculture sector is also providing a boost to the market growth. They are used to analyze plant growth hormones and conduct pesticide residue analysis to ensure that the crops are free of contaminants. In the food and beverage industry, these columns are used to analyze volatile flavor components in fresh and processed food products and conducting chemical studies of oxidative breakdown of fats and lipids by micro-organisms. Other factors, including the increasing demand for single-use products and extensive research and development (R&D) activities in biotechnology, are expected to drive the market further. Looking forward, the analyst expects the global prepacked chromatography columns market to continue its moderate growth during the next five years.
Breakup by Application: Resin Screening Protein Purification Sample Preparation Anion and Cation Exchange Others
Breakup by End-Use: Pharmaceutical and Biotechnology Companies Research Laboratories Water and Environmental Food and Beverages Others
Breakup by Region: North America United States Canada Asia Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa
Competitive Landscape: The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Knauer Wissenschaftliche Geräte GmbH, Merck & Co. Inc., Pall Corporation (Danaher Corporation), Repligen Corporation, Shimadzu Corporation, Thermo Fisher Scientific Inc., Tosoh Corporation, Waters Corporation, etc.
Key Questions Answered in This Report: How has the global prepacked chromatography columns market performed so far and how will it perform in the coming years? What are the key regional markets? What has been the impact of COVID-19 on the global prepacked chromatography columns market? What is the breakup of the market based on the type? What is the breakup of the market based on the technique? What is the breakup of the market based on the application? What is the breakup of the market based on the end-use? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global prepacked chromatography columns market and who are the key players? What is the degree of competition in the industry?
Our reports have been used by over 10K customers, including:
The Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021 report. The report provides a detailed understanding and analysis of how, why and on what terms companies enter discovery stage partnering deals. These deals are discovery stage whereby the licensee obtains a right or an option...
The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2021 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets. The report provides a detailed understanding and analysis of how and why companies enter business, product,...
Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 220.127.116.11) - Drugs in Development, 2021 Summary Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 18.104.22.168) - Histone deacetylase 8 is an enzyme encoded by the HDAC8 gene. It is responsible for the deacetylation of lysine...
120 pages •
By Infiniti Research Limited
• Mar 2021
Global Pharmacovigilance And Drug Safety Software Market 2021-2025 The analyst has been monitoring the pharmacovigilance and drug safety software market and it is poised to grow by $ 66.51 mn during 2021-2025 progressing at a CAGR of 7% during the forecast period. Our report on pharmacovigilance and drug safety software...
Readers of one of the analyst’s media partners were invited to participate in an online survey in September 2020 that centered on the state of their laboratories in 2020 and their expectations for 2021.The analyst has conducted similar studies among the same targeted respondents since 2012.
Where applicable, the study presents year-over-year...
703 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• Mar 2021
Active Pharmaceutical Ingredients (APIs) are active substances in a drug intended to achieve pharmacological activity which is having a direct effect on disease treatment. APIs are synthesized by chemical synthesis, fermentation, biotechnological methods or enhanced from the natural source. According to the analysis,...
The Global Electronic Clinical Outcome Assessment Solution Market (eCOA) size is expected to reach $2.4 billion by 2026, rising at a market growth of 19% CAGR during the forecast period. Electronic clinical outcome assessment (eCOA) refers to a system that is capable of measuring mental state, patient symptom, and the prognosis of a disease....
Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report ’Interleukin 1 - Drugs in Development, 2021’; Interleukin 1 (IL1) pipeline Target constitutes close to 36 molecules. Out of which approximately 35 molecules are developed by companies and remaining...
139 pages •
By Global Industry Analysts
• Apr 2021
- Global Q-TOF Mass Spectrometry Market to Reach $1.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Q-TOF Mass Spectrometry estimated at US$786.5 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at a CAGR of 6.3% over the analysis period...
140 pages •
By Global Industry Analysts
• Apr 2021
- Global Chiral Chromatography Column Market to Reach $117.9 Million by 2027
- Amid the COVID-19 crisis, the global market for Chiral Chromatography Column estimated at US$83.1 Million in the year 2020, is projected to reach a revised size of US$117.9 Million by 2027, growing at a CAGR of 5.1% over the analysis...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.